Invited Faculty
The chart is organized in alphabetical order by last name.
-
Stephen A. Boorjian
Director, Urologic Oncology Fellowship Mayo Clinic, United States
Stephen A. Boorjian
Director, Urologic Oncology Fellowship Mayo Clinic, United States
-
John Denstedt
Department of Urology, Western University, Canada
John Denstedt
Department of Urology, Western University, Canada
UAA Lecture Topic: Kidney Stones; It's Not All about Surgery
-
Albert El Hajj
Department of Surgery, Division of Urology, American University of Beirut Medical Center, Lebanon
Albert El Hajj
Department of Surgery, Division of Urology, American University of Beirut Medical Center, Lebanon
AAU Lecture Topic: Robotic Flexible Ureterorenoscopy— Gimmick or a True Helper? What's It Cost Performance Value?
Dr Albert El Hajj is an Associate Professor and Head of the Urology Division at the American University of Beirut Medical Center. He is the medical director of the Surgery Clinics and Codirector of the Artificial Intelligence in Medicine (AIM) center. After graduating from the Saint Joseph University in Beirut, he completed his robotic and minimally invasive surgery fellowship in Paris. He joined AUBMC in July 2013 where he founded the Robotic Urology program. Dr El Hajj’s main clinical and research interests are Robotic Surgery, Endourology and Prostate Cancer. -
Freddie C. Hamdy
Head, Nuffield Department of Surgical Sciences, University of Oxford, United Kingdom
Freddie C. Hamdy
Head, Nuffield Department of Surgical Sciences, University of Oxford, United Kingdom
BJUI Lecture Topic: 2025 ProtecT Trial update & the caveats of its generalizability
Freddie C. Hamdy joined the University of Oxford in 2008 as Nuffield Professor of Surgery and Head of the Nuffield Department of Surgical Sciences, Professor of Urology, and Honorary Consultant Urological Surgeon, as well as Fellow of Balliol College. He trained in Surgery and Urology at Liverpool, Sheffield and Newcastle, and was founding chair of Urology, Director of the Section of Oncology and of the Division of Clinical Sciences at Sheffield. He introduced a robot-assisted surgical programme to Oxford in 2009, led the Oxford NIHR BRC (Biomedical Research Centre) Surgical Innovation and Evaluation Theme, and was founding co-Director of the first Surgical Intervention Trials Unit at Oxford in the UK. His research activities include clinical, translational and basic science programmes on the biology of urological malignancies. He is Chief Investigator of many studies including the HTA NIHR ProtecT trial on prostate cancer, the largest of its kind which changed clinical practice worldwide, and conducted a pioneering first-in-man trial of image-guided surgery in prostate cancer using molecularly targeted fluorescence. He was Director of the Division of Surgery, Women’s and Oncology at the Oxford University Hospitals NHS Foundation Trust between 2010-2020. He has raised over £80 million in peer-reviewed research income, and published over 500 peer-reviewed manuscripts. He was elected Fellow of the Academy of Medical Sciences in 2007, NIHR Senior Investigator in 2010, and became Editor-in-Chief of the British Journal of Urology International in 2020. He was appointed CBE by HM King Charles in 2024 for services to surgical and cancer sciences. -
Hann-Chorng Kuo
Chairman, Hualien Tzu Chi Hospital and Tzu Chi Medical Foundation, Taiwan
Hann-Chorng Kuo
Chairman, Hualien Tzu Chi Hospital and Tzu Chi Medical Foundation, Taiwan
ACU Lecture Topic: Videourodynamic Study for Precision Diagnosis and Management of Lower Urinary Tract Dysfunction
Professor Hann-Chorng Kuo was graduated from National Taiwan University (NTUH) in 1979. He received his residency training for four years after serving in the army. He was promoted as a visiting staff in NTUH and lecture of the National Taiwan University in 1985. Then he went to Hofuf, Saudi Arabia and served in Hofuf General Hospital for one year as a diplomatic supportive doctor. In 1988, Hann-Chorng moved to Tzu Chi General Hospital, Hualien, Taiwan and served as the chief of the department of Urology in Tzu Chi General Hospital (TCGH) till now. Currently Hann-Chorng is also the vice Chief Executive Officer of the Buddhist Tzu Chi Medical Foundation and is in charge of the research advance of the Tzu Chi General Hospital group.
He devoted himself into clinical and research works in neurourology and urodynamics, and has published more than 709 peer reviewed papers. Dr. Kuo's research interests involve urodynamics, lower urinary tract symptoms, interstitial cystitis, overactive bladder, spinal cord injury, neurogenic lower urinary tract dysfunction, and basic sciences. In recent 20 years, he has a great interest in application of using botulinum toxin injection in treatment of lower urinary tract dysfunction, including neurogenic and non-neurogenic detrusor overactivity, voiding dysfunction due to urethral sphincter dyscoordination, and interstitial cystitis. He had received invitation to give lectures and workshops in Singapore, Hong Kong, Japan and Korea for the technics and application of botulinum toxin treatment on functional urology. He had also been invited to attend AUA, EAU, JUA, KUA, and UAA for special lecture and speakers in thematic symposia.
In 2015 UAA in Taiwan, Hann-Chorng had been in charge of the workshop of the simulative surgery held in the Tzu Chi University, Hualien, Taiwan. The simulative surgery workshop was the first one workshop using whole body cadaver to perform laparoscopic surgery, pelvic floor surgery and dissection, which had inspired many participants about the humanity in urological medicine. The 2025 UAA in Taiwan will also have a simulative surgery workshop in Hualien and Hann-Chorng will again be in charge of this workshop.
Hann-Chorng had gained his professor title in Tzu Chi University School of Medicine in 2001. He was the president of the Taiwan Continence Society (TCS) in 2006 through 2012 and was the president of Taiwan Urological Association (TUA) from 2014 t0 2016. In the field of scientific journals, he currently is the Editor-in-Chief of the Tzu Chi Medical Journal, associate editor of LUTS, Continence (official journal of International Continence Society), and Urological Science (Taiwan), member of the advisory board of Nature Review Urology, and is the editor of British Journal of Urology International, International Brazil Journal of Urology, International Neurourology Journal, Korean Journal of Urology, and Current Bladder Reports. -
Chi Wai Man
Consultant Urologist, Tuen Mun Hospital, Hong Kong
Chi Wai Man
Consultant Urologist, Tuen Mun Hospital, Hong Kong
Honorary Member Lecture Topic: Learning through Giving Expert Opinion, a HK Case Book
Dr MAN is Consultant Urologist of Department of Surgery at Tuen Mun Hospital & Pok Oi Hospital. He had served as Chief of Service of the Department, Chairman of the Coordinating Committee of Surgery and Chairman of the Specialty Group in Urology Services in the Hospital Authority of Hong Kong. He is a general urologist with particular interest in bladder reconstruction, prostate cancer and stone disease. Dr Man graduated from the University of Hong Kong in 1981. He has been elected Fellow of the Royal College of Surgeons of Edinburgh and Glasgow, College of Surgeons of Hong Kong and Hong Kong Academy of Medicine. He is a Specialist in Urology in Hong Kong. He is holder of Diploma of Urology (London) with distinction and Schering Prize, and also Diploma of Child Health (London). In addition to his medical qualifications, Dr Man is also a Bachelor in Laws at Beijing University, China. In urology education, Dr Man has helped to establish higher urology training programmes at the Tuen Mun and Pok Oi Hospitals in Hong Kong. He is a member of the Board of Examiners for the joint Urology Examination of the Royal College of Surgeons of Edinburgh, UK, and the College of Surgeons of Hong Kong. He is a Past President of the Hong Kong Urological Association and had served as Honorary Secretary of the College of Surgeons of Hong Kong, Chairman of the Urology Board and 1st vice President of the Federation of Medical Societies of Hong Kong. He is a Past President of the Urological Association of Asia and he had held honorary advisory positions within the China Doctors’ Association Urology Chapter, the Hong Kong College of Urological Nurses and the Macao Surgical Association. He spends his spare time in reading and gardening. -
Jeremy Y. C. Teoh
Associate Professor & Assistant Dean (External Affairs), Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
Jeremy Y. C. Teoh
Associate Professor & Assistant Dean (External Affairs), Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
SIU Lecture: Role of MISTs in Male LUTS Surgical Management (Will TUR-P/ Laser Prostatectomy be Replaced?)
Jeremy is an oncological surgeon with primary interest in bladder cancer. Previously, he conducted a randomised trial comparing between bipolar and monopolar transurethral resection of bladder tumour (TURBT) and showed that bipolar TURBT was able to achieve a higher detrusor sampling rate than monopolar TURBT. He has also developed a global consensus statement on en bloc resection of bladder tumour (ERBT). A total of 99 statements reached consensus and they have become the standard reference for urologists practising en bloc resection globally. Recently, he published the results of the EB-StaR study, which is a multi-centre randomised trial demonstrating that ERBT could reduce the 1-year recurrence rate from 38.1% to 28.5% for patients with ≤3cm non-muscle-invasive bladder cancer (NMIBC). He is also leading a phase 2 clinical trial on modified en bloc resection for large bladder tumours (>3cm). He is currently serving as a panel member of the European Association of Urology (EAU) Guidelines on NMIBC and Upper Tract Urothelial Carcinoma, and he is dedicated to high-quality research work in this area.
Jeremy has received numerous research grants with a total funding of more than 10 million USD. He has published more than 400 articles in peer-reviewed journals such as European Urology, European Urology Oncology, European Urology Focus and Nature Reviews Urology. He was the Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong (2019-2021), the Chair of the Young Fellows Chapter of the Hong Kong Academy of Medicine (2021-2022), and he has been the Director of the Lions Kidney Educational Centre & Research Foundation since 2017. He is also the founder of the UroSoMe (Urology Social Media) working group and he believes that social media plays an important role in the modern era of medicine.